These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17389449)

  • 21. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
    Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    Baumgart P
    MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
    [No Abstract]   [Full Text] [Related]  

  • 23. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis.
    Bangalore S; Wild D; Parkar S; Kukin M; Messerli FH
    J Am Coll Cardiol; 2008 Sep; 52(13):1062-72. PubMed ID: 18848139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative strokes and beta-blockade.
    Poldermans D; Schouten O; van Lier F; Hoeks SE; van de Ven L; Stolker RJ; Fleisher LA
    Anesthesiology; 2009 Nov; 111(5):940-5. PubMed ID: 19786861
    [No Abstract]   [Full Text] [Related]  

  • 25. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
    Kountz DS
    Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta blockers for the treatment of primary hypertension.
    Khan N; McAlister FA
    Lancet; 2006 Jan; 367(9506):208; author reply 210. PubMed ID: 16427485
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal and stroke protection in hypertensive patients at CV risk.
    Cardiovasc J Afr; 2007; 18(5):337, 340. PubMed ID: 17985036
    [No Abstract]   [Full Text] [Related]  

  • 28. Increasing perioperative beta-blocker utilization: a successful quality improvement project.
    Fernando SK; Atlas SA
    Am J Med; 2005 Jul; 118(7):802-3. PubMed ID: 15989922
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical inquiries. Which patients undergoing noncardiac surgery benefit from perioperative beta-blockers?
    Haynes J; Kelsberg G; Jamieson B; Lo V
    J Fam Pract; 2008 Feb; 57(2):121-3. PubMed ID: 18248734
    [No Abstract]   [Full Text] [Related]  

  • 30. Are beta blockers effective first-line treatments for hypertension?
    Cayley WE
    Am Fam Physician; 2007 Nov; 76(9):1306-8. PubMed ID: 18019872
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study).
    Smebye ML; Iversen EK; Høieggen A; Flaa A; Os I; Kjeldsen SE; Olsen MH; Chattopadhyay A; Hille DA; Lyle PA; Devereux RB; Dahlöf B
    Am J Cardiol; 2007 Sep; 100(5):855-9. PubMed ID: 17719333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meta-analysis finds cardioprotective effects: renaissance of hormone replacement therapy? Interview by Katharina Arnheim].
    Kuhl H
    MMW Fortschr Med; 2006 Jun; 148(26):14. PubMed ID: 16878361
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antihypertensive action of a beta-blocker: value of a controlled therapeutic trial].
    Safar M; Maiz HB; Weiss Y; Lagrue G; Milliez P
    Therapeutique; 1973; 49(7):459-62. PubMed ID: 4150742
    [No Abstract]   [Full Text] [Related]  

  • 34. beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk.
    Kaafarani HM; Atluri PV; Thornby J; Itani KM
    Arch Surg; 2008 Oct; 143(10):940-4; discussion 944. PubMed ID: 18936371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiology -- an update].
    Hoppe UC; Erdmann E
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1435-7. PubMed ID: 16794969
    [No Abstract]   [Full Text] [Related]  

  • 37. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blockers as fourth-line therapy for hypertension: stay the course.
    Bangalore S; Messerli FH
    Int J Clin Pract; 2008 Nov; 62(11):1643-6. PubMed ID: 19143852
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there a heart rate paradox--demystification of the myths?
    Kjekshus J
    J Intern Med; 2009 Sep; 266(3):242-7. PubMed ID: 19702792
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH; Bangalore S; Yao SS; Steinberg JS
    J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.